Â·
x

sicv  iCEs'

DEPARTMENT  OF HEALTH  &  HUMAN  SERVICES 

Public  Health  Service

Food  and  Drug  Administration
9200  Corporate  Boulevard
Rockville  MD  20850

FEB  - 9 2009

Ms.  Rachel  Weissbrod
Director  of Regulatory  Affairs
Oridion  Capnography,  Incorporated
c/o  Oridion  Medical  1987  Limited
Har  Hotzvim  Science  Park,  POB  45025
Jerusalem
Israel  91450

Re:  K082268

Trade/Device  Name:  Capnostream20
Regulation  Number:  870.2700
Regulation  Name:  Oximeter
Regulatory  Class:  II
Product  Code:  DQA,  CCK
Dated:  January  9,  2009
Received:  January  27,  2009

Dear  Ms.  Weissbrod:

We  have  reviewed  your  Section  510(k)  premarket  notification  of intent to  market the  device
referenced  above  and  have  determined  the device  is  substantially  equivalent  (for  the
indications  for use  stated  in  the enclosure)  to  legally  marketed  predicate  devices  marketed  in
interstate  commerce  prior to  May  28,  1976,  the  enactment  date  of the Medical  Device
Amendments,  or to  devices  that  have  been  reclassified  in  accordance  with the provisions  of
the  Federal  Food,  Drug, and  Cosmetic  Act (Act)  that  do not require  approval  of a premarket
approval  application  (PMA).  You may,  therefore,  market  the device,  subject  tO  the  general
controls  provisions  of the  Act.  The  general  controls  provisions  of the Act  include
requirements  for annual  registration,  listing of devices,  good  manufacturing  practice,
labeling,  and  prohibitions  against misbranding  and  adulteration.

If your device  is  classified  (see  above)  into  either  class II (Special  Controls)  or  class  III
(PMA),  it  may be  subject  to  such  additional  controls.  Existing major  regulations  affecting
your device  can  be  found  in the  Code  of Federal  Regulations,  Title  21,  Parts  800  to  898.  In
addition,  FDA  may  publish  further  announcements  concerning  your device  in  the  Federal
Register.

